Nifty
:
25299.35
Sensex
:
81911.01
44.30 (0.18%)
31.61 (0.04%)
Nifty
Sensex
:
:
25299.35
81911.01
44.30 (0.18%)
31.61 (0.04%)

Apollo Hospitals Enterprise Ltd.

Hospital & Healthcare Services

Rating :
63/99

BSE: 508869 | NSE: APOLLOHOSP

NSE BSE
8515.00
12-Nov-2026
  • Open
  • High
  • Low
  • Previous Close
  •  8537.5
  •  8537.5
  •  8454.5
  •  8604.00
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  347669
  •  2954447956
  •  9070.5
  •  6696.5

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 1,22,382.31
  • 54.58
  • 5
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 1,26,606.31
  • 0.24%
  • 11.54

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 28.02%
  • 0.67%
  • 4.46%
  • FII
  • DII
  • Others
  • 43.19%
  • 21.20%
  • 2.46%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 13.27
  • 11.46
  • 9.80

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 18.22
  • 11.52
  • 9.53

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 24.27
  • 13.12
  • 29.28

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 81.56
  • 73.36
  • 72.76

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 10.66
  • 12.16
  • 12.76

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 31.28
  • 33.12
  • 34.25

Earnings Forecasts:

(Updated: 07-11-2026)
Description
2026
2027
2028
2029
Adj EPS
135.04
170.2
216.77
270.3
P/E Ratio
63.06
50.03
39.28
31.50
Revenue
25228.5
29826.7
35059.4
41017.6
EBITDA
3769.3
4610.79
5601.94
6646.54
Net Income
1941.7
2461.28
3121.74
3866.24
ROA
9.06
10.29
12.02
13.34
P/B Ratio
12.91
10.34
8.36
6.69
ROE
21.95
22.54
23.16
23.17
FCFF
712.2
1958.94
2421.27
3457.76
FCFF Yield
0.56
1.54
1.9
2.72
Net Debt
6359.6
3478.3
2029.08
-12.8
BVPS
659.33
823.49
1018.53
1273.04

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Sep 26
Sep 25
Var%
Jun 26
Jun 25
Var%
Mar 26
Mar 25
Var%
Dec 25
Dec 24
Var%
Net Sales
7,614.90
6,188.80
23.04%
7,043.50
5,842.10
20.56%
6,605.50
5,592.20
18.12%
6,477.40
5,526.90
17.20%
Expenses
6,424.10
5,264.40
22.03%
5,951.40
4,990.20
19.26%
5,594.50
4,822.50
16.01%
5,512.10
4,765.40
15.67%
EBITDA
1,190.80
924.40
28.82%
1,092.10
851.90
28.20%
1,011.00
769.70
31.35%
965.30
761.50
26.76%
EBIDTM
15.64%
14.94%
15.51%
14.58%
15.31%
13.76%
14.90%
13.78%
Other Income
44.80
54.50
-17.80%
48.80
40.20
21.39%
43.90
61.10
-28.15%
52.80
63.80
-17.24%
Interest
114.00
98.60
15.62%
120.40
108.30
11.17%
119.10
114.80
3.75%
112.60
109.80
2.55%
Depreciation
230.20
205.30
12.13%
235.10
214.70
9.50%
224.40
211.00
6.35%
219.20
184.60
18.74%
PBT
891.40
675.00
32.06%
785.40
569.10
38.01%
711.40
505.00
40.87%
667.10
530.90
25.65%
Tax
244.90
180.70
35.53%
188.40
141.70
32.96%
170.20
101.00
68.51%
165.70
156.80
5.68%
PAT
646.50
494.30
30.79%
597.00
427.40
39.68%
541.20
404.00
33.96%
501.40
374.10
34.03%
PATM
8.49%
7.99%
8.48%
7.32%
8.19%
7.22%
7.74%
6.77%
EPS
43.80
33.19
31.97%
40.39
30.10
34.19%
36.81
27.09
35.88%
34.93
25.89
34.92%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 26
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Net Sales
27,741.30
25,228.50
21,794.00
19,059.20
16,612.50
14,662.60
10,560.00
11,246.80
9,617.40
8,243.47
7,255.70
Net Sales Growth
19.83%
15.76%
14.35%
14.73%
13.30%
38.85%
-6.11%
16.94%
16.67%
13.61%
 
Cost Of Goods Sold
14,333.10
13,075.60
11,310.00
9,805.50
8,574.30
7,573.50
5,684.20
5,498.90
4,660.90
4,032.66
3,598.88
Gross Profit
13,408.20
12,152.90
10,484.00
9,253.70
8,038.20
7,089.10
4,875.80
5,747.90
4,956.50
4,210.81
3,656.83
GP Margin
48.33%
48.17%
48.10%
48.55%
48.39%
48.35%
46.17%
51.11%
51.54%
51.08%
50.40%
Total Expenditure
23,482.10
21,459.20
18,772.20
16,668.50
14,562.90
12,477.50
9,426.90
9,665.80
8,554.70
7,452.09
6,548.95
Power & Fuel Cost
-
281.40
266.20
247.20
217.50
193.70
169.70
213.00
183.80
166.68
127.89
% Of Sales
-
1.12%
1.22%
1.30%
1.31%
1.32%
1.61%
1.89%
1.91%
2.02%
1.76%
Employee Cost
-
3,000.30
2,769.20
2,493.70
2,176.70
1,786.50
1,601.00
1,852.90
1,598.20
1,404.39
1,196.50
% Of Sales
-
11.89%
12.71%
13.08%
13.10%
12.18%
15.16%
16.47%
16.62%
17.04%
16.49%
Manufacturing Exp.
-
3,182.30
2,612.00
2,290.90
1,981.00
1,800.80
1,055.00
1,154.30
982.30
905.65
785.07
% Of Sales
-
12.61%
11.98%
12.02%
11.92%
12.28%
9.99%
10.26%
10.21%
10.99%
10.82%
General & Admin Exp.
-
1,689.90
1,634.50
1,707.10
1,494.40
1,009.10
691.40
716.30
988.70
817.35
744.85
% Of Sales
-
6.70%
7.50%
8.96%
9.00%
6.88%
6.55%
6.37%
10.28%
9.92%
10.27%
Selling & Distn. Exp.
-
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
% Of Sales
-
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
Miscellaneous Exp.
-
229.70
180.30
124.10
119.00
113.90
225.60
230.40
140.80
125.35
0.00
% Of Sales
-
0.91%
0.83%
0.65%
0.72%
0.78%
2.14%
2.05%
1.46%
1.52%
1.32%
EBITDA
4,259.20
3,769.30
3,021.80
2,390.70
2,049.60
2,185.10
1,133.10
1,581.00
1,062.70
791.38
706.75
EBITDA Margin
15.35%
14.94%
13.87%
12.54%
12.34%
14.90%
10.73%
14.06%
11.05%
9.60%
9.74%
Other Income
190.30
191.60
200.30
106.30
90.30
78.20
49.10
33.20
32.40
33.95
44.33
Interest
466.10
449.60
458.50
449.40
380.80
378.60
449.20
532.80
327.00
295.07
257.35
Depreciation
908.90
876.10
757.50
687.00
615.40
600.70
573.10
619.70
395.50
359.03
314.04
PBT
3,055.30
2,635.20
2,006.10
1,360.60
1,143.70
1,284.00
159.90
461.70
372.60
171.24
179.69
Tax
769.20
658.20
534.00
445.50
256.20
477.00
84.70
225.10
173.40
111.91
90.96
Tax Rate
25.18%
25.16%
26.62%
32.70%
22.40%
30.23%
38.38%
34.11%
46.54%
65.35%
50.62%
PAT
2,286.10
1,941.70
1,445.90
898.60
862.30
1,048.30
149.60
458.00
235.00
117.42
220.99
PAT before Minority Interest
2,190.80
2,002.70
1,505.10
935.00
887.50
1,101.10
136.00
434.90
199.20
59.56
131.12
Minority Interest
-95.30
-61.00
-59.20
-36.40
-25.20
-52.80
13.60
23.10
35.80
57.86
89.87
PAT Margin
8.24%
7.70%
6.63%
4.71%
5.19%
7.15%
1.42%
4.07%
2.44%
1.42%
3.05%
PAT Growth
34.49%
34.29%
60.91%
4.21%
-17.74%
600.74%
-67.34%
94.89%
100.14%
-46.87%
 
EPS
158.98
135.03
100.55
62.49
59.97
72.90
10.40
31.85
16.34
8.17
15.37

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 26
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Shareholder's Funds
9,480.10
8,212.30
6,935.40
6,197.40
5,623.30
4,602.50
3,339.10
3,333.50
3,251.51
3,313.20
Share Capital
71.90
71.90
71.90
71.90
71.90
71.90
69.60
69.60
69.56
73.01
Total Reserves
9,016.20
7,855.30
6,691.10
6,040.60
5,542.50
4,524.30
3,266.50
3,261.10
3,180.05
3,238.91
Non-Current Liabilities
6,191.00
7,778.30
5,033.90
6,225.50
6,242.00
5,590.10
6,482.70
4,613.00
4,423.17
4,398.65
Secured Loans
2,424.60
1,967.30
2,231.40
1,923.70
2,408.20
2,466.00
2,852.00
2,868.70
2,728.43
2,477.64
Unsecured Loans
5.50
2,449.70
4.20
13.90
19.00
7.40
0.00
83.40
195.37
475.74
Long Term Provisions
563.50
454.40
349.90
1,723.40
1,341.60
1,061.00
1,011.20
883.00
784.96
701.39
Current Liabilities
6,487.30
4,579.40
4,664.50
3,324.90
2,434.30
2,038.00
2,337.30
1,955.40
1,567.23
963.36
Trade Payables
2,251.80
2,240.50
2,368.60
1,915.60
1,631.80
1,160.00
908.80
713.10
606.02
501.19
Other Current Liabilities
1,078.30
1,635.90
1,425.90
684.80
472.10
382.40
807.80
640.80
501.70
295.59
Short Term Borrowings
2,953.30
521.60
725.30
609.10
208.50
385.90
497.50
498.20
379.17
70.69
Short Term Provisions
203.90
181.40
144.70
115.40
121.90
109.70
123.20
103.30
80.33
95.89
Total Liabilities
22,652.80
21,010.60
17,018.90
16,081.70
14,579.30
12,430.50
12,289.80
10,037.40
9,374.35
8,799.79
Net Block
12,269.40
10,985.40
9,660.50
8,515.70
8,290.90
6,773.00
7,426.20
4,975.10
4,765.71
4,583.29
Gross Block
18,242.30
16,180.60
14,193.30
12,473.20
11,717.50
9,612.40
10,222.00
6,599.50
6,023.63
5,499.02
Accumulated Depreciation
5,972.90
5,195.20
4,532.80
3,957.50
3,426.60
2,839.40
2,795.80
1,624.40
1,257.92
915.73
Non Current Assets
15,747.00
13,981.20
11,739.20
11,744.70
10,518.70
8,789.00
9,643.00
7,755.60
7,154.22
6,670.57
Capital Work in Progress
1,032.40
921.00
872.80
609.90
45.50
233.90
235.60
821.80
712.20
346.86
Non Current Investment
1,162.20
1,054.50
302.10
281.40
314.80
344.90
359.20
392.80
294.12
300.20
Long Term Loans & Adv.
1,083.50
944.20
833.90
2,178.80
1,769.30
1,421.30
1,598.40
1,431.60
1,254.62
1,325.53
Other Non Current Assets
197.30
73.30
66.50
154.80
93.50
10.60
17.70
127.80
120.43
106.93
Current Assets
6,905.80
7,029.40
5,279.70
4,337.00
4,060.60
3,641.50
2,646.80
2,281.80
2,220.13
2,129.22
Current Investments
1,016.50
1,432.30
684.00
292.20
501.30
997.80
74.90
68.80
57.87
105.84
Inventories
542.40
480.80
459.80
390.10
431.90
249.50
737.80
584.70
565.84
466.87
Sundry Debtors
3,484.90
3,016.10
2,514.90
2,234.20
1,764.70
1,331.10
1,027.20
1,023.20
825.19
750.53
Cash & Bank
1,116.80
1,360.20
933.80
775.80
924.00
724.40
466.80
346.90
417.25
524.50
Other Current Assets
745.20
287.40
258.20
226.40
438.70
338.70
340.10
258.20
353.97
281.47
Short Term Loans & Adv.
451.70
452.60
429.00
418.30
297.70
193.90
163.00
152.90
177.57
223.03
Net Current Assets
418.50
2,450.00
615.20
1,012.10
1,626.30
1,603.50
309.50
326.40
652.90
1,165.86
Total Assets
22,652.80
21,010.60
17,018.90
16,081.70
14,579.30
12,430.50
12,289.80
10,037.40
9,374.35
8,799.79

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 26
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Cash From Operating Activity
2,855.70
2,136.40
1,920.20
1,376.90
1,696.00
1,264.50
1,292.90
905.20
536.96
622.55
PBT
2,660.90
2,031.40
1,380.50
1,100.50
1,578.10
221.50
656.90
373.60
59.56
131.12
Adjustment
1,374.60
1,194.90
1,199.20
1,108.40
681.40
1,079.80
1,012.50
770.10
807.85
703.53
Changes in Working Capital
-574.00
-603.90
-192.80
-450.00
-359.20
-72.10
-70.40
-46.00
-205.35
-78.48
Cash after chg. in Working capital
3,461.50
2,622.40
2,386.90
1,758.90
1,900.30
1,229.20
1,599.00
1,097.70
662.06
756.17
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-605.80
-486.00
-466.70
-382.00
-204.30
35.30
-306.10
-192.50
-125.10
-133.62
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-2,148.20
-3,383.00
-1,537.20
-870.60
-847.20
-863.40
-288.80
-710.60
-404.91
-1,151.88
Net Fixed Assets
-1,030.80
-830.60
-1,399.90
-324.10
-166.80
1,127.70
-2,378.60
-622.09
-796.57
-582.72
Net Investments
-982.00
-1,289.50
-404.00
-158.10
31.60
-1,014.40
9.00
-185.02
163.48
-186.58
Others
-135.40
-1,262.90
266.70
-388.40
-712.00
-976.70
2,080.80
96.51
228.18
-382.58
Cash from Financing Activity
-477.60
1,319.20
-311.10
-633.00
-791.60
-340.10
-909.60
-214.70
-108.50
476.95
Net Cash Inflow / Outflow
229.90
72.60
71.90
-126.70
57.20
61.00
94.50
-20.10
23.55
-52.37
Opening Cash & Equivalents
578.10
505.50
433.50
546.30
388.70
380.70
286.20
306.30
282.78
335.15
Closing Cash & Equivalent
811.30
578.10
505.50
433.40
546.50
425.20
380.70
286.20
306.33
282.78

Financial Ratios

Consolidated /

Standalone
Description
Mar 26
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Book Value (Rs.)
632.00
551.27
469.76
424.53
389.89
319.08
239.10
238.71
233.02
237.25
ROA
9.17%
7.92%
5.65%
5.79%
8.15%
1.10%
3.90%
2.05%
0.65%
1.10%
ROE
23.54%
20.50%
14.54%
15.16%
21.60%
3.44%
13.08%
6.07%
1.81%
2.68%
ROCE
21.73%
21.19%
19.27%
17.78%
24.92%
9.32%
17.13%
10.24%
7.12%
6.94%
Fixed Asset Turnover
1.47
1.44
1.43
1.37
1.37
1.06
1.34
1.52
1.43
1.44
Receivable days
47.03
46.32
45.47
43.93
38.53
40.76
33.27
35.08
34.88
34.21
Inventory Days
7.40
7.88
8.14
9.03
8.48
17.06
21.46
21.83
22.86
21.96
Payable days
62.70
74.37
79.74
75.50
67.27
66.42
34.00
33.10
31.52
33.88
Cash Conversion Cycle
-8.27
-20.18
-26.12
-22.54
-20.26
-8.60
20.73
23.81
26.22
22.28
Total Debt/Equity
0.62
0.67
0.47
0.44
0.47
0.62
1.08
1.10
1.06
0.95
Interest Cover
6.92
5.45
4.07
4.00
5.17
1.49
2.24
2.14
1.58
1.70

Annual Reports:

FY 2026
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
FY 2019
FY 2018
FY 2017

News Update:


  • Apollo Hospitals’ consolidated net profit grows 32% in Q2
    5th Nov 2026, 10:30 AM

    The total consolidated income of the company has increased by 22.69% at Rs 7,659.70 crore for Q2FY27

    Read More
  • Apollo Hospital Ent. - Quarterly Results
    5th Nov 2026, 00:00 AM

    Read More
  • Apollo Hospitals’ consolidated net profit rises 34% in Q1
    13th Aug 2026, 10:50 AM

    The total consolidated income of the company has increased by 20.57% at Rs 7,092.30 crore for Q1FY27

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.